Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 2003, p. 2298-2305, Vol. 69, No. 4
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.4.2298-2305.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Jörg Mampel,
Alasdair M. Cook, and Jürgen Ruff*
Department of Biology, The University of Konstanz, D-78457 Konstanz, Germany
Received 3 October 2002/ Accepted 23 January 2003
|
|
|---|
|
|
|---|
![]() View larger version (19K): [in a new window] |
FIG. 1. Degradation of TSA and TCA to amphibolic intermediates by C. testosteroni T-2 and the four regulons involved (R1 to R4) (9, 29, 36). Reactions of gene products that are encoded by chromosomal genes are in insets. Regulatory units R1 (pTSA) and R3 (pT2L) are plasmid encoded (42; Ruff, unpublished). The tsa regulon is sketched schematically, with the directions of transcription indicated by shaded triangles. TsaMB, p-toluenesulfonate methylmonooxygenase (oxygenase M, reductase B); TsaC, p-sulfobenzylalcohol dehydrogenase; TsaD, p-sulfobenzaldehyde dehydrogenase; PszA(C), p-sulfobenzoate-3,4-dioxygenase.
|
70 promoters, putative ribosomal binding sites, and transcriptional start, Pribnow box, and -35 regions (13). We now confirm that TsaR, examined as the His-tagged TsaRHis, is the major regulator of expression of tsaMBCD in C. testosteroni T-2, and we describe some of its properties and interactions with the promoter region.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. C. testosteroni T-2 and some mutants and the substrates they utilize
|
pir[pUT-Tc] was kindly provided by M. Kertesz and grown as described previously (10). E. coli DH5
[pJB866], as the donor of the broad-host-range vector pJB866 (GenBank accession no. U8200), was kindly provided by J. M. Blatny and grown as described previously (3). The E. coli host strain M15[pREP4] (Qiagen, Hilden, Germany), which contains an isopropyl-ß-D-thiogalactopyranoside (IPTG)-inducible expression system, and the derived clone M10 (see below) were grown with Luria-Bertani (LB) medium (33) with 25 µg of kanamycin/ml and 100 µg of ampicillin/ml, respectively, according to the manufacturer's recommendations.
PCR, quantification of DNA, cycle sequencing, and Southern hybridization.
PCR was done in a final volume of 20 to 50 µl. All reaction mixtures contained 10% (vol/vol) dimethyl sulfoxide. Genomic DNA (180 to 200 ng), prepared by cetyltrimethylammonium bromide precipitation (1), or a bacterial culture was used as the template. Templates (
5 kb) were amplified with Taq polymerase (MBI Fermentas) in buffer system 2 of the Expand Long PCR system (Roche) or (>5 kb) with the Expand Long PCR System (Roche). The latter has a proofreading activity and was also used for the generation of PCR products designed for cloning. Reactions were done according to the manufacturers' recommendations. DNA was quantified fluorimetrically (DyNA Quant 200; Hoefer) according to the manufacturer's instructions. Primers used for PCR are listed in Table 2. The Tn5 insertions were localized in strain 4A10 with primer pair TsaReg1-TsaReg2. The template for sequencing the Tn5 insertion in strain 4A10 was amplified with primer pair TsaRu1-AntiRu1; the sequencing primers were TsaIG1, TsaReg4, and Tn55-Out.
|
View this table: [in a new window] |
TABLE 2. PCR primers used in this study
|
The amplified template for cycle sequencing was purified with the Qiaquick PCR purification kit (Qiagen), and the fragment (85 ng of DNA/kb) was added to the sequencing reaction mixture (ABI Prism Big Dye terminator kit; Applied Biosystems) and subjected to the following PCR program: 70 s at 95°C and then 26 cycles of 20 s at 95°C, 30 s at 50°C, and 4 min at 60°C. The sequence was determined by capillary electrophoreses (GATC, Konstanz, Germany). Using standard software (Edit View [Perkin Elmer], a GCG program package, and DNA-STAR [Lasergene]) and the neural network analysis for prokaryotic promoters software of M. G. Reese (http://searchlauncher.bcm.tmc.edu/seq-search/gene-search.html) (11; M. G. Reese and F. H. Eeckman, abstract from the Proceedings of the Seventh International Genome Sequencing and Analysis Conference, vol. 1, no. 1, p. 45, 1995, and M. G. Reese, N. L. Harris, and F. H. Eeckman, poster from the Proceedings of the 1996 Pacific Symposium, Biocomputing, 1996), we analyzed the sequence data on the basis of characterized E. coli promoters.
Southern blot hybridization was done as described elsewhere (24). Gene probes were generated according to the manufacturer's instructions by digestion with EcoRI (New England BioLabs) of pUT-Tc carrying Tn5. The 2.1-kb fragment was labeled with a DIG system (Roche) and used as a gene probe to confirm the presence of the Tn5 insertion on pTSA.
The DNA markers used were the 0.1- and 1-kb ladders (MBI Fermentas), with ranges of 0.1 to 3 kb and 0.25 to 10 kb, respectively.
Pulsed-field gel electrophoresis.
DNA was prepared from whole cells embedded in low-melting-point agarose as described elsewhere (38). Electrophoresis was done as described previously (42).
Transposon mutagenesis, competent cells, and cloning.
The mini-Tn5 transposon mutagenesis system (10) was used to knock out tsaR in C. testosteroni T-2. E. coli S17-I
pir[pUT-Tc] (6 x 109 cells; donor) was mated with C. testosteroni T-2 (2 x 109 cells; recipient) on LB agar at 30°C for 48 h. Prior to mating, cells were centrifuged separately, washed twice, resuspended in 0.9% (wt/vol) sterile NaCl solution, and mixed before a 50-µl volume was applied to the LB agar plate. Cells were then scraped off the agar and washed once with 0.9% (wt/vol) NaCl. Dilution series were plated on minimal agar with PCA or succinate as the carbon and energy source (antidonor selection) and 15 µg of tetracycline/ml (selection for the Tn5 marker). A total of 7,500 mutants were characterized for growth with TSA, TCA, PSB, or terephthalate (TER) in microtiter plates. Mutants unable to grow on TSA or TCA were further analyzed, because this phenotype is expected from a knockout of tsaR (Fig. 1) (or of tsaMBCD). A total of 5
of the mutants corresponded to this phenotype, but only one tsaR-negative mutant was obtained.
Vectors with inserts were introduced into target cells either by electroporation or by chemical transformation. Cells of C. testosteroni were prepared for electroporation as described previously (23, 33, 43) and electroporated with 0.2 to 1 µg of DNA at 15 kV/cm in a Gene Pulser II (Bio-Rad) with 125 µF of capacity, 200
of resistance, and a 4.8 x 10-3-s pulse. Chemical transformation was done with E. coli M15[pREP4] according to the supplier's instructions (QIAexpress Kit Type ATG; Qiagen).
Three recombinant organisms were generated. First, C. testosteroni 4A10 (Table 1) was generated from C. testosteroni T-2 by Tn5 transposon mutagenesis; the insertion was in tsaR. Second, C. testosteroni TT6 was generated from mutant 4A10 (Table 2); it contained wild-type tsaR in trans. The tsaR gene from strain T-2 was amplified with primers CT1 and CT2 (Table 2) and modified by nested PCR to encode a C-terminal, sixfold His tag (tsaRhis). For that purpose, the reverse primer, tsaRHisHindIII, encoded a C-terminal His tag upstream of a stop codon and a restriction site for HindIII. A restriction site for AflIII was generated in the forward primer, tsaRAflIII, by replacing the original start codon, GTG, with ATG plus a subsequent TTG (leucine) codon. The construct generated by PCR was cloned into the broad-host-range vector pJB866 under the control of a promoter inducible by 2 mM m-toluate. This plasmid was electroporated into mutant 4A10 to yield mutant TT6 (Table 1). Third, E. coli M10 was constructed from E. coli M15[pREP4] to express TsaRHis. The tsaR gene from strain T-2 was ligated into pQE-70, which encodes a His tag. The insert was generated from the PCR-amplified template (primers CT1 and CT2; see above) and modified by nested PCR. The primer pair was tsaRSphI, in which the original start codon was replaced with ATG and a subsequent CTC (leucine) codon to generate a restriction site for SphI, and tsaRBglII, in which the original stop codon was replaced with TCT and AGA (serine and arginine) to fuse TsaR to the C-terminal His tag of pQE-70 and create a BglII restriction site. This plasmid was introduced into E. coli M15 by chemical transformation.
Preparation of TsaRHis, Western blotting, and determination of molecular mass under native and denaturing conditions.
Suspensions of chilled E. coli M10 were disrupted by sonication (3 bursts for 1 s at 70 W, on ice), and TsaR was purified under native conditions as described elsewhere (QIAexpress kit type ATG; Qiagen) and stored in 20% glycerol at -20°C. Immunological detection of purified TsaRHis after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was done by Western blotting following standard protocols (32), which were modified as necessary according to the antibody's manufacturer. Monoclonal antibodies (QIAexpress detection kit and Tetra-His antibody) against a fourfold His epitope were provided by Qiagen; anti-mouse immunoglobulin coupled to alkaline phosphatase (Roche) was used as secondary antibody, and detection was done with a disodium 3-(4-methoxyspiro (1,2-dioxetane-3,2'-(5'-chloro) tricyclo [3.3.1.13,7] decan)-4-yl)phenyl phosphate system (CSPD; Roche). The molecular mass of TsaRHis was estimated by gel filtration chromatography on a Superose 12 column calibrated with chymotrypsin, ovalbumin, bovine serum albumin, and aldolase (molecular mass values of 25, 43, 67, and 158 kDa, respectively). The mobile phase was 10 mM Tris, pH 7.0, containing 150 mM NaCl; the loading buffer was the elution buffer of the QIAexpress kit.
Denatured proteins were separated on SDS-PAGE (34) and stained with either standard (33) or colloidal (27) Coomassie brilliant blue. The protein markers used were a low-range marker (6.5, 14.4, 21.5, 31, 45, 66.2, and 97.4 kDa; Bio-Rad) and a 10-kDa protein ladder (10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, and 200 kDa; Gibco). Soluble protein was quantified according to Bradford (4).
DNA-binding assays (20-µl volumes).
Binding of TsaRHis to DNA was assayed by incubation of freshly prepared TsaRHis with 100 ng of PCR-amplified target DNA in binding buffer (5 mM Tris/HCl, 20 mM NaCl, 8 mM MgCl2, 10% glycerol, 1.5 M fresh 2-mercaptoethanol, 30 µg of freshly added bovine serum albumin/ml, pH 8.0) for 40 min on ice. Binding assays of TsaRHis were done with 2 µg of protein, and assays to determine KD, the dissociation constant, were done with 0.3 to 1.5 µg of protein. KD was defined as the protein concentration at which 50% of the target DNA molecules were occupied, as assayed by band shift. The influence of TSA (0.01 to 6 mM) on the binding of TsaRHis to DNA was measured at constant protein concentration (30.6 µg/ml). Samples for analysis were supplemented (10% [vol/vol]) with a solution of 15% Ficoll containing 0.25% bromophenol blue and subjected to standard agarose gel electrophoresis (33) in 1.5% agarose at 14.7 V/cm. Staining with ethidium bromide and destaining (33) were done after electrophoresis to exclude intercalation into the DNA during separation. Stained gels were documented (Gel Doc 1000; Bio-Rad) and subject to densitometric analysis (Multi-Analyst software for Macintosh, version 1.02; Bio-Rad Laboratories, Hercules, Calif.).
Nucleotide sequence accession number.
The putative promoter region sequence and partial gene sequence of pszA are available in the National Center for Biotechnology Information GenBank library under accession number AY044257.
|
|
|---|
Mutant 4A10 grew with neither TSA nor TCA, and growth with PSB was poor (Table 1). In contrast, construct TT6 (Table 1) showed utilization of TSA, TCA, or PSB in the presence of 2 mM m-toluate to induce TsaRHis; substrate utilization was determined by high-performance liquid chromatography. Inducible expression of TsaRHis in strain TT6 was confirmed by SDS-PAGE. Using antibodies against the His tag, separated proteins from crude extracts of cells grown in the presence or absence of m-toluate were subjected to Western blotting; only induced cells showed cross-reactivity, with a single band at about 33 kDa (Fig. 2B and data not shown). This proved that TsaR is a gene product which is essential for expression of tsaMBCD in C. testosteroni T-2. It also showed that the function of TsaR is not significantly affected by the C-terminal His tag.
![]() View larger version (116K): [in a new window] |
FIG. 2. Expression and purification of TsaRHis from E. coli strain M10 monitored by SDS-PAGE (A) and Western blot analysis (B). E. coli M10 was grown in the absence and presence of IPTG, the inducer of expression of tsaRhis. Soluble proteins from disrupted cells were compared; TsaRHis from induced cells was purified, and the His tag was identified immunologically. Lanes 1 and 8, calibration proteins with the molecular mass values given; lane 2, extract of noninduced cells; lane 3, extract of induced cells; lane 4, supernatant fluid after addition of nickel-agarose; lane 5, supernatant fluid from wash 1 of the purification protocol; lane 6, supernatant fluid from wash 2 of the purification protocol; lane 7, purified TsaRHis.
|
Preliminary binding studies showed that TsaRHis rapidly lost its ability to bind DNA within 5 h of cell disruption, unless it was stored under an atmosphere of nitrogen. Under the latter conditions, binding capacity was retained for at least 1 month. Samples with low levels of binding capacity were able to be restored to full capacity by incubation under nitrogen. Reproducible binding of TsaRHis to its target DNA in vitro required the presence of high concentrations of 2-mercaptoethanol (1.5 M instead of the millimolar concentrations which are often used; for an example, see reference 25). Binding assays had to be done quickly, because even under optimal conditions, all activity was lost after 20 min. We presume that TsaR is sensitive to oxygen.
This rapid loss of binding capacity, and the requirement for 1.5 M mercaptoethanol, ruled out the use of standard footprint assays. We chose to avoid radiochemical techniques, so standard band shift assays of DNA binding (1) were not applicable and other approaches were developed.
DNA-binding assays with TsaRHis and with specific fragments of DNA from promoter and coding regions were done in parallel, which compensated for the addition of competitor DNA normally used in radioactive DNA-binding assays to ensure sequence-specific binding of the protein. TsaRHis did not bind significantly to a coding region of the tsa operon (tsaMcod) (Table 3 and Fig. 3A); the mobility of the DNA fragments was unaltered by the presence of TsaRHis. The protein did cause a band shift when the putative promoter region was examined (tsaprom) (Table 3 and Fig. 3), and the DNA fragment was shifted completely by addition of 1.5 µM TsaRHis (tsaprom; Fig. 3B). We were concerned that TsaRHis might interact with a putative promoter region(s), so we explored the interaction with the appropriate region of the locus encoding PSB dioxygenase (Fig. 1) (pszAprom; Table 3). TsaRHis had no interaction with that fragment of DNA (pszAprom; Fig. 3B). TsaR is thus a DNA-binding protein specific for the tsa promoter region. The dissociation constant (KD [Materials and Methods]) of TsaRHis for the tsa promoter region (tsaprom; Table 3) was found to be 0.9 µM.
|
View this table: [in a new window] |
TABLE 3. PCR products used for DNA-binding assays
|
![]() View larger version (54K): [in a new window] |
FIG. 3. Band shift assays with TsaRHis and specific fragments of DNA from C. testosteroni T-2. (A) tsaMcod, coding region of tsaMB (Table 3) used as a negative control for nonspecific DNA binding; (B) tsaprom, promoter region between tsaR and tsaM (Table 3); pszAprom, promoter of pszA (Table 3) used as a control for promoter specificity of DNA binding of TsaRHis.
|
![]() View larger version (11K): [in a new window] |
FIG. 4. The effect of TSA concentration on the band shift of tsaprom caused by TsaRHis.
|
![]() View larger version (27K): [in a new window] |
FIG. 5. Sequence and structure near the tsa promoter region. The nucleotide positions are those of U32622 (13). Data from genes tsaR (both strands) and tsaM are in uppercase characters, with the start codons in bold characters; amino acids are in uppercase italic characters. The putative ribosomal binding site (*1), transcriptional start (*2), Pribnow box (*3), and -35 (*4) regions are in bold characters and are underlined for tsaR and shaded grey for tsaM. Subfragments 1 to 5 (Table 3) are indicated with pairs of arrows. The dashed line indicates putative DNA-binding sites for TsaRHis in the presence of TSA (I and III), and the dotted line indicates the putative binding site for TsaRHis in absence of TSA (IV); the binding region II is also shown with a dotted line with terminal arrows. An overview depicting subfragments 1 to 5 with the binding sites and the requirement of TSA is sketched below the sequence.
|
|
View this table: [in a new window] |
TABLE 4. Band shifts with TsaRHis and subfragments of the tsaR/tsaMBCD regulona
|
|
|
|---|
Knockout mutant 4A10 failed to grow with both TSA and TCA (Fig. 1), and utilization of both substrates was restored in mutant TT6 (Table 1). We thus confirmed the prediction that TsaR regulates the degradation of both compounds (13, 36); the gene products from tsaMBCD are used in the initial attacks on each substrate (Fig. 1) (21). Tralau et al. (unpublished data) showed that mutants in TSA transport prevent neither growth with TCA, which has a different transport system (22), nor normal growth with PSB, for which TsaB is required to complement the missing PszC (9, 14; J. Ruff, unpublished data) (Fig. 1). We thus conclude that tsaMBCD is directly affected by the knocking out of tsaR and that failure to grow is not a result of, e.g., positional effects.
Mutant 4A10 grew poorly with PSB (Table 1), and the deleterious effect of the mutation was corrected on complementation of TsaR (mutant TT6; Table 1). The surprise is that mutant 4A10 grew at all with PSB, given that TsaB is required to complement the missing PszC. We presume that an unidentified reductase is able to complement PszC partially.
Gel filtration chromatography indicated that active TsaR is a monomer in solution, though le Maire et al. (18) warn of errors sometimes encountered with this method. TsaR as the active monomer differs from several LysR-type regulators. One example of a monomeric regulator exists, AmpR (31), whereas ClcR is a dimer (6) and CysB and OxyR are tetramers (16, 44).
TsaR is sensitive to oxygen. Thus, gel filtration chromatography could not be done with TsaRHis bound to DNA. So it was impossible to determine whether the dissolved monomeric TsaRHis binds to its target sequence in a multimeric form, as LysR-type regulators usually do. We examined band shifts in agarose gels instead of polyacrylamide gels for the same reason, because separation is faster, thus allowing us to assay the interaction with DNA before TsaR lost its binding capacity.
It is unclear what interaction causes this oxygen sensitivity. Redox sensitivity has been described previously for the DNA-binding regulator FurS (ferric iron uptake) in Streptomyces reticuli, for which the effect is attributed to the redox state of cysteine residues (28). There was no sequence similarity between TsaR and FurS, so we presume that a different interaction occurs between oxygen and TsaR. Furthermore, reactivation of TsaR under nitrogen occurs in the absence of a reducing agent; the biochemical mechanism of this oxygen sensitivity is unknown. Given that TsaR regulates an operon encoding an oxygenase (TsaMB; Fig. 1) (13, 19) and that it seems to be a negative autoregulator (Tralau et al., unpublished), this sensitivity to oxygen may be useful to the cell. TsaR is very stable in the cell (Tralau et al., unpublished). One possible explanation is that TsaR in its active conformation is stable under conditions in which oxygen levels were low. This would reduce the turnover of active TsaR, and the transcription of the tsa operon would be repressed efficiently, because all binding sites would be occupied. Alternatively, the stability of TsaR would decrease in the presence of oxygen. This would increase the turnover of TsaR and allow transcription of the tsa operon to start more easily. The mechanism might thus help to compensate for the relatively high KD value (0.9 µM). This value is of the same magnitude as that for CatR, the regulator for catechol degradation at its internal binding site in catB in Pseudomonas putida (5), whereas the DNA-binding regulator ModE (26) shows higher affinity for its target promoter (24 nM).
The modulation by TSA of the interaction of TsaRHis with the whole intergenic tsaprom fragment (Fig. 4) involves regulatory sites for the expression of both tsaR and tsaMBCD, and we observed single shifts with this fragment only (Fig. 3). When we used shorter fragments of DNA, we obtained evidence for four binding regions and some double shifts, whose nature we do not understand (Table 4). Presumably the resolution of the agarose gels allowed double shifts to be detected with short fragments only. We realize that the multiple binding regions prevent a quantitative evaluation of the data presented in Fig. 4, but they imply that the system can react in a finely tuned manner. We also do not know how the ligands TSA and oxygen interact during the binding of TsaR to its target sites. However, regulatory complexity is already apparent at the physiological level, e.g., in defined mixed cultures utilizing multiple substrates (41).
Up to four binding sites for TsaR can be deduced in the sequence of tsaprom (Table 3 and Fig. 5), three of which may be derived from the consensus sequences (T-N11-A) presented by Schell for LysR-type regulators (35). BS I at positions 1376 to 1389 was proposed previously (13) and now has experimental support (subfragment I; Table 4). The location of BS II was not defined experimentally (Table 4 and Fig. 5), but of two possible binding motifs (35) at positions 1397 to 1409 and positions 1434 to 1446, the latter could bind TsaRHis without blocking the putative ribosomal binding site, the transcriptional start, the Pribnow box, or the -35 region for gene tsaR. We tentatively located BS III at positions 1562 to 1574 near the 5' end of tsaM; this site, derived from the consensus sequence, may contribute to the double shift with subfragment 2 (Table 4), but this could not be confirmed experimentally (subfragment 5; Table 4). BS IV, at positions 1384 to 1396, has clear experimental support in the absence of TSA (subfragment 4; Table 4).
We propose that in the absence of TSA, TsaR interacts at BS IV, which blocks the transcription of tsaR. In the presence of TSA, the regulator would shift to BS II (presumably position 1434 to 1446), thereby releasing the repression of transcription for tsaR and activating transcription of tsaMBCD. The existence of two additional binding sites is uncommon for LysR-type regulatory systems (35). The marginal activity of BS III resembles a situation seen with the CatR system in the catBCA operon of P. putida, which possibly represents a mechanism to save energy by reducing enzyme synthesis (5); induced TsaM represents 5% of soluble protein (19). The role of BS I may be involved with synthesis of TsaR, which reaches micromolar concentrations during growth (Tralau et al., unpublished).
T.T. and J.M. were funded by the Deutsche Forschungsgemeinschaft (through A.M.C. and J.R.), the EU project SUITE (to A.M.C.), the University of Konstanz, and the Fonds der Chemischen Industrie.
Present address: School of Biological Sciences, University of Manchester, Manchester, United Kingdom. ![]()
Present address: Institute of Biotechnology, Swiss Federal Institute of Technology, Zürich, Switzerland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»